This episode, Sam is joined by Sophie Mouros to discuss: a clinical trial fraud case involving allegedly fabricated data, the FDA’s withdrawal from the medical device Global Harmonization Working Party, the FDA’s recent guidance addressing utilizing computational modeling and simulation for medical devices, and the FDA’s active enforcement against manufacturers who fail to comply with unique device identifier (UDI) requirements.